GB0020794D0 - Humanised antibodies - Google Patents

Humanised antibodies

Info

Publication number
GB0020794D0
GB0020794D0 GB0020794A GB0020794A GB0020794D0 GB 0020794 D0 GB0020794 D0 GB 0020794D0 GB 0020794 A GB0020794 A GB 0020794A GB 0020794 A GB0020794 A GB 0020794A GB 0020794 D0 GB0020794 D0 GB 0020794D0
Authority
GB
United Kingdom
Prior art keywords
humanised antibodies
humanised
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0020794A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scancell Ltd
Original Assignee
Scancell Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scancell Ltd filed Critical Scancell Ltd
Priority to GB0020794A priority Critical patent/GB0020794D0/en
Publication of GB0020794D0 publication Critical patent/GB0020794D0/en
Priority to KR10-2002-7015240A priority patent/KR100480985B1/en
Priority to BR0110927-8A priority patent/BR0110927A/en
Priority to PCT/GB2001/002226 priority patent/WO2001088138A1/en
Priority to AU2001258567A priority patent/AU2001258567A1/en
Priority to JP2001584520A priority patent/JP2003533987A/en
Priority to DE60116753T priority patent/DE60116753T2/en
Priority to US10/258,728 priority patent/US20040091485A1/en
Priority to ES01931876T priority patent/ES2259030T3/en
Priority to CA002409361A priority patent/CA2409361A1/en
Priority to EP01931876A priority patent/EP1278851B1/en
Priority to CNB018106412A priority patent/CN1239701C/en
Priority to AT01931876T priority patent/ATE316137T1/en
Priority to US11/478,657 priority patent/US20060240003A1/en
Priority to US12/155,986 priority patent/US20080260735A1/en
Ceased legal-status Critical Current

Links

GB0020794A 2000-05-19 2000-08-24 Humanised antibodies Ceased GB0020794D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GB0020794A GB0020794D0 (en) 2000-08-24 2000-08-24 Humanised antibodies
AT01931876T ATE316137T1 (en) 2000-05-19 2001-05-21 HUMANIZED ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR
DE60116753T DE60116753T2 (en) 2000-05-19 2001-05-21 HUMANIZED ANTIBODIES AGAINST THE EPIDERMAL GROWTH FACTOR RECEPTOR
ES01931876T ES2259030T3 (en) 2000-05-19 2001-05-21 HUMANIZED ANTIBODIES AGAINST THE RECEIVER OF THE EPIDERMAL GROWTH FACTOR.
PCT/GB2001/002226 WO2001088138A1 (en) 2000-05-19 2001-05-21 Humanised antibodies to the epidermal growth factor receptor
AU2001258567A AU2001258567A1 (en) 2000-05-19 2001-05-21 Humanised antibodies to the epidermal growth factor receptor
JP2001584520A JP2003533987A (en) 2000-05-19 2001-05-21 Humanized antibodies against epidermal growth factor receptor
KR10-2002-7015240A KR100480985B1 (en) 2000-05-19 2001-05-21 Humanized antibodies to the epidermal growth factor receptor
US10/258,728 US20040091485A1 (en) 2000-05-19 2001-05-21 Humanised antibodies to the epidermal growth factor receptor
BR0110927-8A BR0110927A (en) 2000-05-19 2001-05-21 Antibody, nucleic acid, vector, cell, method of making an antibody, pharmaceutical composition, use of an antibody or nucleic acid, and method for treating or prophylaxis of cancer
CA002409361A CA2409361A1 (en) 2000-05-19 2001-05-21 Humanised antibodies to the epidermal growth factor receptor
EP01931876A EP1278851B1 (en) 2000-05-19 2001-05-21 Humanised antibodies to the epidermal growth factor receptor
CNB018106412A CN1239701C (en) 2000-05-19 2001-05-21 Humanised antibodies to epidermal growth factor receptor
US11/478,657 US20060240003A1 (en) 2000-05-19 2006-07-03 Humanised antibodies to the epidermal growth factor receptor
US12/155,986 US20080260735A1 (en) 2000-05-19 2008-06-12 Transfer request (37 CFR 1.821(e)) humanised antibodies to the epidermal growth factor receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0020794A GB0020794D0 (en) 2000-08-24 2000-08-24 Humanised antibodies

Publications (1)

Publication Number Publication Date
GB0020794D0 true GB0020794D0 (en) 2000-10-11

Family

ID=9898162

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0020794A Ceased GB0020794D0 (en) 2000-05-19 2000-08-24 Humanised antibodies

Country Status (1)

Country Link
GB (1) GB0020794D0 (en)

Similar Documents

Publication Publication Date Title
IL156030A0 (en) Humanized antibodies
AU1174702A (en) Humanized anti-lt-beta-r antibodies
GB0029360D0 (en) Humanised antibodies and uses thereof
HUP0300841A3 (en) Agonist anti-trk-c monoclonal antibodies
EP1432444A4 (en) Anti-a-beta antibodies
HK1074206A1 (en) Anti-trail-r antibodies
IL166244A0 (en) Super humanized antibodies
EP1073464A4 (en) Monoclonal antibodies with reduced immunogenicity
GB9809839D0 (en) Antibody
EP1264885A4 (en) Antibody library
GB9911569D0 (en) Antibodies
AU2002365649A8 (en) Anti-dota antibody
IL136459A0 (en) Antibody library
EP1178829A4 (en) Human monoclonal antibody
GB9818915D0 (en) Antibodies
GB9828700D0 (en) Antibody
EP1278538A4 (en) Cd18-binding antibodies inhibit stenosis-related disorders
GB0020794D0 (en) Humanised antibodies
EP1446416A4 (en) Tumor specific monoclonal antibodies
GB0003359D0 (en) Monoclonal antibodies
GB0008160D0 (en) Monoclonal antibodies
AU2001295042A1 (en) Anti-stilbene antibodies
GB0029846D0 (en) Monoclonal antibody
GB0030139D0 (en) Monoclonal antibody
GB0031284D0 (en) High affinity antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)